2Topoi EJ, Traill TA, Fortuin NJ , et al. Hypertensive hypertrophic cardimnyopathy of the elderly. N Engl J Med, 1985, 312: 277-283.
3Shiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiog, 1989, 2: 358-367.
4D'Amico A, Graziano C, Pacileo G, et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord. 2006, 16: 548-552.
6Lewis JF, Maron BJ. Elderly patients with hypertrophic cardionayopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coil Cardiol, 1989, 13: 36-45.
7Shapiro LM. Hypertrophic cardiomyopathy in the elderly. Br Heart J, 1990, 63: 265-266.
8Karam R, Lever HM, Healy BP. Hypertensive hypertrophic eardiomyopathy or hypertrophic cardiomyopathy with hypertension ? A study of 78 patients. J Am Coil Cardiol, 1989, 13 : 580-584.
9Kim SW, Park SW, Lim SH, et al. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction. Clin Cardiol, 2006, 29:155-160.
10Arteaga E, Araujo AQ, Buck P, et al. Plasma amino-terminal pro-B- type natriuretic peptide quantification in hypertrophic cardiomyopathy, Am Heart J, 2005, 150: 1228-1232.
